Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis
帕克替尼是一种强效的ACVR1抑制剂,可显著改善骨髓纤维化患者的贫血症状。
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2023010151
Oh, Stephen T; Mesa, Ruben A; Harrison, Claire N; Bose, Prithviraj; Gerds, Aaron T; Gupta, Vikas; Scott, Bart L; Kiladjian, Jean-Jacques; Lucchesi, Alessandro; Kong, Tim; Buckley, Sarah A; Tyavanagimatt, Shanthakumar; Harder, Bryan G; Roman-Torres, Karisse; Smith, Jennifer; Craig, Adam R; Mascarenhas, John; Verstovsek, Srdan